Pharmaceutical Product Information

Tecentriq® (atezolizumab)

  • Concentrate for solution for infusion (IV) 1200 mg/20 ml

  • Concentrate for solution for infusion (IV) 840 mg/14 ml

Should you face issues with accessing the product information, please contact us via:

Mondays to Thursdays: 8am to 5pm
Fridays: 8am to 3pm
Telephone:
Email: